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A B S T R A C T
Baroreflex sensitivity (BRS) has been proposed as a diagnostic parameter for neurological
disorders and as a survival-prognosis parameter in diabetic and cardiac patients. Therefore
reference values and the reproducibility of BRS were assessed, taking into account the possible
influence of age, gender, test conditions and some analysis variants. Healthy subjects (nfl 191)
were randomly selected from the 50–75-year-old general population (the Hoorn Study).
Variations in blood pressure and heart rate were recorded non-invasively during three breathing
modes: spontaneous (3 min), slow metronome (1 min; 6 breaths/minfl 0.1 Hz) and fast
metronome (1 min; 15 breaths/minfl 0.25 Hz), all in a supine position. From these recordings,
BRS was assessed as the transfer gain between changes in blood pressure and heart period, and
as the a coefficient. BRS values ranged from 5.0 to 8.9 ms[mmHg−1. Slow metronome breathing
resulted in higher BRS values than fast breathing, while during spontaneous breathing BRS in the
low-frequency band was lower than that in the high-frequency band (respiratory origin). BRS
values decreased with lower coherence criteria. BRS-a was significantly higher than BRS-gain.
While regression analysis showed no gender differences, BRS decreased with age. Therefore age-
specific reference values were calculated. The reproducibility of BRS values was in general
moderate, with reliability coefficients ranging from 43 to 81% and coefficients of variation
ranging from 34 to 59%. In conclusion, this study shows age, breathing mode, frequency and
coherence threshold to affect measures of BRS. Therefore these factors should be considered in
clinical studies ; appropriate reference values are given.
INTRODUCTION
The baroreceptor heart rate reflex, or baroreflex, is the
fastest blood pressure buffering mechanism. In reaction
to variations in blood pressure, detected by stretch
receptors located mainly in the aortic arch and the carotid
sinus, the baroreflex modulates cardiac vagal and
sympathetic outflow to the sinus node in the heart.
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This baroreflex control of heart rate can be quantified by
baroreflex sensitivity (BRS), which represents the amount
of change in heart rate attributable to changes in systolic
blood pressure.
BRS has been proposed as a new parameter to assess
autonomic dysfunction in subjects with diabetes [1–4], in
addition to or even as a substitute for the standard
cardiovascular autonomic function tests (i.e. the deep
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breathing test, the lying-to-standing test, the Valsalva
manoeuvre and the sustained handgrip test [3,5,6]).
Besides its application in the assessment of cardiovascular
autonomic function in diabetic patients, BRS has been
introduced in cardiology for risk stratification after
myocardial infarction [7,8]. However, reference values of
BRS have not been assessed for a well-documented
general population, and data on reproducibility are
scarce, and have not yet been assessed for subjects of
advanced age.
The classic procedure for assessing the sensitivity of
the baroreceptor heart rate reflex involves the measure-
ment of intra-arterial blood pressure and reflex heart
period changes caused by an intravenous bolus injection
of phenylephrine [9]. Non-invasive methods to assess
BRS are now available, based on measurements of finger
arterial blood pressure (Finapres2) and the joint analysis
of spontaneous coherent changes in blood pressure and
heart rate [10–13]. Three methods are the most common:
the sequence technique [14], which is a time-domain
method, and two frequency-domain methods: the spec-
tral technique to assess the so-called a coefficient [10],
and the cross-spectral technique to estimate the gain of
the transfer function between changes in blood pressure
and heart period [12,13,15,16]. In the present study we
have used the two frequency-domain methods.
All three methods are based on the assumption that
changes in heart period are driven by independent
(systolic) changes in blood pressure through the baro-
reflex. It is commonly thought that the coherence, which
corresponds to the correlation coefficient in the time-
domain analysis, reflects this coupling between blood
pressure and heart rate. It is therefore the case that a
threshold is imposed on the coherence to increase the
specificity of the estimates of BRS. However, any choice
of this threshold would be arbitrary, but becomes
pertinent in cases of low BRS values.
The sequence technique, the a coefficient and the
transfer function method all assess dynamic features of
the baroreflex control of heart rate, and not its steady-
state value. Since it is known that the gain of the transfer
function changes with frequency [16], the choice of the
frequency bandwidth will also have an influence on BRS
estimation.
Breathing evokes highly coherent changes in blood
pressure and heart rate, and metronome breathing allows
this exogenous stimulation to be associated with bands of
a particular frequency. On the other hand, breathing may
also cause non-baroreceptor-mediated changes in heart
rate [11,16].
In order to address all these possible influences on
BRS, the present paper reports reference values for BRS
in a population sample of 50–75-year-old subjects,
estimated by the transfer function gain and the a
coefficient, from recordings in the supine position, during
spontaneous breathing as well as metronome breathing at
6 or 15 breaths per min. Furthermore, the impact of the
coherence criterium and the reproducibility of BRS are
addressed.
METHODS
Study population
For the present analyses, data were obtained from the
Hoorn Study, in which 2484 Caucasian men and women,
born between 1914 and 1940, participated in 1989 and
1990. The study population and research design have
been described in detail previously [17]. The study was
originally conducted to assess the prevalence of glucose
intolerance and diabetes-related disorders, in particular
cardiovascular diseases. Therefore, a 75 g oral glucose
tolerance test (OGTT) was performed. An age-, gender-
and glucose-tolerance-stratified sample (708 subjects)
was invited for a second OGTT within 3–5 weeks, and
subjects were requested to undergo an extensive physical
examination, including autonomic function tests, on
another day. Of this sample, 631 (89%) participated in
the study. Subjects were classified according to WHO
criteria, based on the mean values of two OGTTs [18].
For this reference value study, only subjects with a
normal glucose tolerance were included. Of the 288
subjects with a normal glucose tolerance, those with
hypertension or prevalent self-reported cardiovascular or
neurological diseases were excluded, resulting in a study
population of 191 healthy subjects.
Reasons for exclusion were : a self-reported history of
neurological disease (five subjects), self-reported chronic
obstructive pulmonary disease (four subjects) and a
history of cardiovascular disease (40 subjects), as assessed
by means of a Dutch translation of the London School of
Hygiene and Tropical Medicine questionnaire [19].
Blood pressure was measured twice before the start of the
OGTT, on both occasions by means of a random zero
mercury sphygmomanometer (Hawksley-Gelman). Ex-
clusion on the basis of hypertension was defined as
current treatment with anti-hypertensive drugs (49 sub-
jects), mean systolic blood pressure over 160 mmHg
and}or mean diastolic blood pressure over 95 mmHg (36
subjects).
Individual data were missing for the following reasons:
the test schedule was not completed, the quality of the
data was insufficient for processing (a poor blood
pressure signal or arrhythmias), or more than 10% non-
sinus beats in the total number of recorded beats.
Of the 631 initial subjects, 43 were invited to partici-
pate in a reproducibility study. Of these, 39 subjects
responded, and were studied for the second time within 3
weeks.
The study protocol was approved by the Ethics
Committee of the Academic Hospital of the Vrije
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Universiteit. All study participants gave their informed
consent.
Autonomic function tests
Participants were asked to refrain from smoking and
drinking coffee for 2 h prior to the assessment of
cardiovascular autonomic function. Tests took place
between 08.30 and 16.00 hours at least 1 h after a light
meal. Subjects rested supine in a quiet ambience, with a
room temperature of between 19 and 22 °C. Tests were
performed using three frequency-determined breathing
modes : (1) slow breathing for 1 min at 6 breaths per min;
(2) fast breathing for 1 min at 15 breaths per min; and (3)
spontaneous breathing for 3 min. The correct frequency
of breathing (6 or 15 breaths per min) was controlled and
dictated by oral and visual instructions of the investigator,
who in turn followed beeps generated by the data-
acquisition program. When off-line spectral analysis of
the systolic blood pressure data showed a clearly
recognizable peak shifted from the expected frequency of
breathing (margins of ‡0.02 Hz), the measurements
were discarded. After each test a resting period of 1 min
was allowed, to prevent an influence of the previous test
conditions.
During the tests, heart rate and blood pressure were
recorded continuously on a PC-based data-acquisition
system. RR intervals were obtained from a bipolar ECG
chest lead by a hardware QRS detector with an accuracy
of 1 ms. Blood pressure was recorded continuously,
using the Finapres2 method (Finger Arterial Blood
Pressure ; Ohmeda BP2000). Finger arterial pressure
recordings were sampled digitally at 200 Hz, and subse-
quently processed. First the blood pressure signal was
low-pass-filtered, after which it was down-sampled
(100 Hz). For each heart beat, values of systolic blood
pressure were obtained from this processed blood press-
ure signal by means of an automatic procedure, which
was verified by visual inspection.
Computation of parameters
BRS was computed as (1) the transfer gain of blood
pressure and heart period changes, and (2) the a
coefficient, a ratio of the changes in heart period and
blood pressure. Both methods will be explained below.
For more detailed information on the computation of the
spectral powers of RR intervals and systolic blood
pressure within the particular frequency bands as used
for both methods of computation, we refer the reader to
a paper by TenVoorde et al. [20].
Transfer function gain: when we consider the baro-
receptor heart rate reflex as a simple linear single-input
single-output system, BRS is the change in heart period
(output) that is caused directly by a unit change of
systolic blood pressure (input), in ms[mmHg−"
[10,12,16,21]. BRS may then be estimated as the gain of
the transfer function between systolic blood pressure and
heart period (see Appendix 1). An additional function can
be derived from systolic blood pressure (input), heart
period (output) and cross-spectra between the two: the
squared coherence (c#). This is a normalized function,
which gives the amount of RR-interval variance that is
linearly explained by the blood pressure variance. The
squared coherence function has a value between 0 and 1:
the higher this value, the higher the coupling between
variations in blood pressure and heart rate.
Transfer gain and coherence are both functions of
frequency (Figure 1). BRS values therefore are defined
for bands of a particular frequency as the average of the
gain values for those frequency components having a
squared coherence value greater than 0.5, as is indicated
by the bold parts of the curves of the transfer functions in
Figure 1 (right-hand panels). These frequency bands
(horizontal arrows in Figure 1) were : for the spontaneous
breathing test a low-frequency (LF) band (0.04–0.12 Hz)
and a high-frequency (HF) band (0.12–0.40 Hz); for the
slow breathing test (6 breaths}min fl 0.10 Hz) the 0.05–
0.15 Hz frequency band; and for the fast breathing test
(15 breaths}min fl 0.25 Hz) the 0.20–0.30 Hz frequency
band. BRS values for these particular breathing rates and
frequency bands are denoted as : BRS-gain-LF, BRS-
gain-HF, BRS-gain-6}min and BRS-gain-15}min. It is
essential to keep in mind that, of these four BRS values,
three are computed from variations in blood pressure and
heart rate caused directly by breathing movements. Only
BRS-gain-LF is based on spontaneous oscillations in
blood pressure and heart rate as they appear in the
frequency band around 0.1 Hz.
The squared coherence threshold of 0.5, although often
applied [13,16], is rather arbitrary. We therefore assessed
the influence of the squared coherence criterium on the
BRS values by applying different thresholds of 0.7, 0.5,
0.3 and 0.0. Both formulae of gain and coherence
functions and their relationship are given in Appendix 1
[13,15,16,21,22].
The a coefficient is defined as the square root of the
ratio of the spectral powers of RR interval and systolic
blood pressure within a band of a particular frequency.
The ratio was only calculated for those points in the
spectrum with a coherence greater than 0.5 [10,23]. Thus,
in contrast with the BRS gain, BRS-a does not include the
coherence, but the coherence is only used as a cut-off
value above which it is valid to compute the BRS
(Appendix 1). The a coefficient was only calculated from
the spontaneous breathing recordings for both the LF
and HF bands, as is generally done, and is denoted as
BRS-a-LF and BRS-a-HF.
Statistical analysis
A normal distribution of all BRS values was obtained by
taking the natural logarithm. For the presentation of the
geometric means, 95% confidence intervals and per-
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Figure 1 An example of cross-spectral analysis of bloodpressure and heart rate and computation of BRS for a healthy woman
(57 years old)
From left to right : left-hand panels show the beat-to-beat series of RR interval (RRI ; ms) and systolic blood pressure (SBP ; mmHg) ; middle panels show the amount
of variance in RRI and SBP as a function of frequency, i.e. power spectra ; right-hand panels show the transfer gain between SBP and RRI and squared coherence as
a function of frequency. From top to bottom : upper panels show the results of the slow metronome breathing test ; middle panels show the results of the fast metronome
breathing test ; lower panels show the results of the spontaneous breathing test. For each breathing mode, different frequency bands are defined as indicated by the
horizontal arrows. Within these frequency bands BRS-gain values are computed as the average transfer gain, including only those spectral components meeting the squared
coherence criterium (bold lines).
Table 1 Characteristics of the healthy elderly study popu-
lation (nfl 191)
HDL, high-density lipoprotein. Values are means‡S.D.
Variable Value
Gender
Men 98
Women 93
Age (years) 62.6‡7.4
Body mass index (kg/m2) 25.5‡3.0
Fasting plasma glucose (mmol/l) 5.4‡0.5
Total cholesterol (mmol/l) 6.6‡1.1
HDL cholesterol (mmol/l) 1.4‡0.4
Triglycerides (mmol/l) 1.5‡0.7
Mean RR interval (ms)
Supine 65‡135
Standing 847‡116
Diastolic blood pressure (mmHg) 78.4‡7.4
Systolic blood pressure (mmHg) 128.1‡12.8
centiles, ln values were back-transformed. To evaluate
the influence of breathing mode on BRS values, paired t-
tests were performed. Two regression models were used
to assess the possible influence of age and gender : (1)
ln(BRS) fla›b
"
[age›b
#
[gender, and (2) ln(BRS) fl
a›b
"
[age, with age in decades and gender as a di-
chotomous variable (0 fl male and 1 fl female). Trans-
formation of BRS was indicated again, now to obtain
normally distributed residuals. Reference values, defined
as the 90% prediction interval for individual predictions,
were computed from the estimated linear regression
parameters, thus optimally using the available measure-
ments [24]. The formulae used are presented in Appendix
2.
For the population for which duplicate measurements
were available, the reliability coefficient (RC) and the
coefficient of variation (CV) were calculated by analysis
of variance to obtain test}retest reliability [25]. Thus:
RC fl S.D.#
between
}(S.D.#
between
›S.D.#
within
)[100%
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with high values of RC representing good repro-
ducibility ; and:
CV fl S.D.
within
}mean
bothmeasurements
[100%
with low values representing good reproducibility.
RESULTS
Reference values
The mean age of subjects in the reference value study was
62.6‡7.4 years (Table 1). As can be seen from Tables 2
and 3, the BRS values differed significantly between the
Table 2 BRS computed as transfer gain and a coefficient
estimated from recordings made under different breathing
conditions in the supine position, in a healthy population
aged 50–75 years
The squared coherence criterium was 0.5. CI, confidence interval. Frequencies :
6/min, 6 breaths/min (0.1 Hz) ; 15/min, 15 breaths/min (0.25 Hz) ; LF,
0.04–0.12 Hz ; HF, 0.12–0.40 Hz. Significance of differences (t-tests) : *P ! 0.05
for metronomic compared with spontaneous breathing ; †P ! 0.05 for LF
compared with HF ; ‡P ! 0.05 for BRS-gain compared with a coefficient.
BRS (ms[mmHg−1)
Geometric mean 95% CI n
Metronome breathing
BRS-gain-6/min 8.5* 7.9 to 9.2 167
BRS-gain-15/min 6.6* 5.9 to 7.4 169
Spontaneous breathing
BRS-gain-LF 6.2 5.6 to 6.8 160
BRS-a-LF 6.6 6.0 to 7.3 149
BRS-gain-HF 7.5 6.7 to 8.3 160
BRS-a-HF 8.6 7.7 to 9.6 157
Table 3 Geometric means of BRS computed as the transfer-function gain with multiple
coherence criteria for the three breathing modes in a healthy population aged 50–75 years
For the case that no squared coherence criterium was applied, i.e. 0.0, the observed squared coherence is given. CI, confidence
interval. Frequencies : 6/min, 6 breaths/min (0.1 Hz) ; 15/min, 15 breaths/min (0.25 Hz) ; LF, 0.04–0.12 Hz ; HF,
0.12–0.40 Hz.
BRS (ms[mmHg−1)
Observed squared
Squared coherence criteria… 0.7 0.5 0.3 0.0 coherence [95% CI]
Metronome breathing
BRS-gain-6/min 8.9 8.5 8.2 7.8 0.73 [0.71 to 0.75]
BRS-gain-15/min 6.9 6.6 6.4 6.0 0.69 [0.67 to 0.71]
Spontaneous breathing
BRS-gain-LF 6.9 6.2 5.7 5.0 0.52 [0.50 to 0.54]
BRS-gain-HF 7.9 7.5 6.9 5.6 0.43 [0.41 to 0.45]
various breathing modes, frequency bands and squared
coherence criteria, ranging from 5.0 to 8.9 ms[mmHg−".
BRS-gain-6}min and BRS-a-HF were higher than any of
the other BRS values measured, and BRS-gain-LF was
the lowest (Table 2). The a coefficients were, in both the
LF and HF bands, higher than the respective transfer
function gains (Table 2).
BRS values increased with increasing coherence criteria
(Table 3), with the greatest increases for BRS-gain-LF
and BRS-gain-HF, i.e. more than 2 ms[mmHg−". The
observed coherence between variations in blood pressure
and heart period was significantly lower for the spon-
taneous breathing data (Table 3, final column ). Mean
squared coherence over the HF band was even below 0.5.
Applying a higher coherence criterium of 0.7 instead of
0.5 (Table 3, first column) led to the exclusion of 27
persons for the spontaneous breathing tests, but none for
the metronomic breathing tests. The excluded persons
were on average 2 years older than those for whom the
BRS could be computed, but they had a comparable
average systolic blood pressure, comparable fasting blood
glucose, comparable HbA
"c
(glycated haemoglobin) and
comparable lipid profiles.
After adjustment for age, the regression analysis
showed no clear consistent differences between males
and females. Therefore no gender-specific reference
values are presented. BRS estimates for the slow metro-
nome test and the spontaneous breathing test decreased
significantly with increasing age, ranging from 0.1 to
0.4 ms[mmHg−" per 10 years. For fast metronome
breathing, the magnitude of the estimate of the regression
coefficient was similar, but it did not attain statistical
significance. Reference values for each BRS value for six
different ages are given in Table 4.
Reproducibility
The mean, RC and CV were calculated for all BRS
values (Table 5). In general, the reproducibility of
BRS values was poor to moderate, with RCs ranging
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Table 4 Reference values for BRS as a function of age
Given are the 90% prediction intervals for individuals, as estimated from the reference population aged 50–75 years (n fl
191). The squared coherence criterium was 0.5. Frequencies : 6/min, 6 breaths/min (0.1 Hz) ; 15/min, 15 breaths/min
(0.25 Hz) ; LF, 0.04–0.12 Hz ; HF, 0.12–0.40 Hz.
BRS (ms[mmHg−1)
Age (years)… 50 55 60 65 70 75
Metronome breathing
BRS-gain-6/min 5% 4.7 4.3 4.0 3.6 3.3 3.0
95% 24.3 22.0 20.0 18.3 16.7 15.3
BRS-gain-15/min 5% 1.8 for all ages
95% 22.7 for all ages
Spontaneous breathing
BRS-gain-LF 5% 3.4 3.0 2.6 2.2 1.9 1.6
95% 23.4 20.0 17.2 14.8 12.8 11.1
BRS-a-LF 5% 3.5 3.0 2.7 2.3 2.0 1.8
95% 24.9 21.6 18.8 16.5 14.4 12.7
BRS-gain-HF 5% 3.9 3.3 2.8 2.3 1.9 1.6
95% 35.0 29.1 24.3 20.4 17.1 14.5
BRS-a-HF 5% 4.8 4.0 3.3 2.7 2.2 1.8
95% 41.8 34.0 27.7 22.6 18.5 15.2
Table 5 Reproducibility of BRS in a 50–75-year-old general
population, expressed as RC and CV
The squared coherence criterium was 0.5. Note that this population was not
selected on the basis of health parameters. Frequencies : 6/min, 6 breaths/min
(0.1 Hz) ; 15/min, 15 breaths/min (0.25 Hz) ; LF, 0.04–0.12 Hz ; HF, 0.12–
0.40 Hz.
Mean BRS
(ms[mmHg−1) RC (%) CV (%) n
Metronome breathing
BRS-gain-6/min 7.7 43 34 36
BRS-gain-15/min 6.2 55 59 27
Spontaneous breathing
BRS-gain-LF 5.1 48 43 28
BRS-a-LF 6.0 50 39 19
BRS-gain-HF 5.5 71 50 27
BRS-a-HF 6.5 81 42 26
from 43 to 81% and CVs ranging from 34 to 59%. BRS-
a-HF had the best reproducibility, with an RC of 81%,
and BRS-gain-6}min had the best (lowest) CV of 34%.
DISCUSSION
The present study reports the 5th and 95th percentiles,
age-specific values for BRS and its reproducibility
in a healthy 50–75-year-old population. We observed
differences in BRS values between the various breathing
modes and frequency bands, and a dependence on
coherence criteria. The observed geometric means varied
between 5.0 and 8.9 ms[mmHg−", thus stressing the
importance of standardization and the use of appropriate
reference values.
Reference group
The reference group was taken from a random sample of
the general population. Only subjects with a normal
glucose tolerance, no cardiovascular diseases, no hy-
pertension and no neurological diseases were selected,
because these conditions are known to lower BRS. As
we did not exclude subjects with subclinical disease, as
may be assessed by more advanced testing, we selected
a population that was representative of the general
healthy population.
The WHO definition for hypertension, i.e. blood
pressure of 160}95 mmHg, was used [26]. Currently,
values between 160 and 140 mmHg systolic and 95 and
90 mmHg diastolic are referred to as mild hypertension,
and this condition is known to be associated with lower
BRS [23]. Therefore we repeated the analyses with the
exclusion of subjects with mild hypertension (results not
shown). Although the average age of the 37 excluded
persons was higher than the age of the remaining 154
persons [66.4 (S.D. 7.3) versus 61.7 (7.1) years], the
estimated decrease with age as assessed by linear re-
gression and the estimated reference values remained
essentially the same. Furthermore, including systolic
blood pressure as a continuous variable in the linear
regression analysis showed no significant association
between systolic blood pressure and measures of BRS.
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Age
The finding that BRS diminishes with age is consistent
with previous findings [23,27]. The present study, how-
ever, extends this finding in a population sample of more
advanced age. One previous study by James et al. [28] did
not observe age-related differences in an elderly popu-
lation aged 60–81 years. However, this might have been
due to the slightly greater age and the 4-fold smaller size
in comparison with our study population. Since BRS
decreased with increasing age, age-specific reference
values are recommended. Observed differences in cut-off
points were substantial, e.g. 3.4 ms[mmHg−" for a person
of 50 years to 1.6 ms[mmHg−" for a person of 75
years of age for BRS-gain-LF in the supine position. La
Rovere et al. [8], in their study addressing the prognostic
value of BRS for survival in patients following myocardial
infarction, used the phenylephrine method and a cut-off
value of 3.0 ms[mmHg−" to define the high-risk group.
Our reference values are close to this value of
3.0 ms[mmHg−", supporting the validity of the definition
of abnormality on a statistical basis. Linden and Diehl
[29] also reported reference values for BRS; unfortu-
nately, they measured RR interval variation with the
Finapres device and not with an ECG, making it less
precise. Further, the reported values were mean values
and not really reference values.
Gender
No differences were found between men and women. In
middle-aged subjects, Huikuri et al. [30] reported gender
differences in BRS: men having higher values
(10.5‡4.6 ms[mmHg−" ; n fl 188) than women
(8.0‡4.6 ms[mmHg−" ; n fl 186). A possible explanation
might be the slightly younger age of the study population.
Moreover, their study population was approximately
twice the size of our study population, thus implying
greater power to detect relatively small differences.
Methodological issues
There is no clear consensus on how to assess BRS non-
invasively. Many different analysis methods and analysis
parameters exist : time domain versus frequency domain,
different spectral algorithms, and bands of different
frequency. The dependence of BRS on several of these
issues was the subject of investigation in the present
study, and will be discussed in the following three
sections. This section elaborates on some additional
methodological issues.
We used slightly different frequency bands compared
with the ESC Task Force recommendations for studies
on heart rate variability [31] (note that BRS assessment
was not part of these recommendations). We positioned
the border frequency between the LF and HF bands at
0.12 Hz, whereas the Task Force on heart rate variability
suggests 0.15 Hz. [31]. We did this because we think that
this will give a better differentiation between respiration-
induced variability (HF) and spontaneous oscillations
(LF). The frequency of spontaneous respiration in the
supine resting position often falls below 0.15 Hz. On the
other hand, the effect of a small shift in this LF-to-HF
border frequency on BRS estimation is expected to be
rather small, since BRS is based on a ratio of heart rate to
blood pressure powers, together with a coherence
criterium.
For a true and unbiased estimate of BRS, it is assumed
that variations in heart rate are secondary to changes in
blood pressure, and thus mediated by the baroreflex. This
does not entirely hold for respiratory-induced variations,
as will be discussed in the next section. Nevertheless we
decided to assess BRS from modulations in spontaneous
breathing (HF band) as well as from variations induced
by metronome breathing (6 and 15 breaths}min), firstly
to estimate the impact of respiration and frequency on
BRS. Secondly, a BRS estimate based on 1 min of
metronome breathing at 6 breaths}min seems a clinically
interesting autonomic function parameter, since from
these differences in heart rate the so-called expiration}
inspiration value (EI-value) can also be computed, which
is one of the oldest and best standardized parameters used
to quantify autonomic dysfunction in diabetes [5,32].
Finally, some comments on our computation of the a
coefficient. Although the definition is not different from
Pagani’s original one [10], the computation of the
underlying power spectra does differ. While Pagani used
an autoregressive method, we used a periodogram-like
method, a modified form of the Discrete Fourier Trans-
form [20]. Both methods are valid ways to estimate the
power spectral density function, although the auto-
regressive method is known to have a better frequency
resolution, in particular for short recordings. However,
in the case of the a coefficient, one applies the power over
the selected frequency band, i.e. spectral components are
summated, and this frequency resolution difference
becomes irrelevant. Moreover, in a study on physio-
logical data, the two power spectral density estimation
methods did not give systematic differences in the BRS
computation, and the reported differences were 10–20
times smaller than the observed inter-individual
differences [33]. A final argument for computing the a
coefficient from the Discrete Fourier Transform spectra
in our study was the possibility of comparing both BRS-
a and BRS-gain results in conjunction with the coherence
criterion, which was an important goal of the present
study, and which will be discussed in the next two
sections.
Frequency dependence and respiration
It is generally accepted that variations in heart rate with
frequencies above 0.15 Hz represent vagal function only,
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while lower frequencies represent both vagal and sym-
pathetic function [16,31]. Furthermore, the dynamic
range of vagal, noradrenergic cardio-chronotropic con-
trol is also limited, with a cut-off frequency estimated at
around 0.2 Hz in the supine position [15,16]. It is
therefore not surprising that we found BRS values to
depend on frequency: the three BRS-gain values
computed from respiratory-induced fluctuations of
6}min, HF and 15}min are 8.5, 7.5 and 6.6 ms[mmHg−"
respectively, with the centre frequencies at which the
BRS was computed being 0.10, 0.20 (mean spontaneous
respiration rate for all subjects) and 0.25 Hz respectively.
BRS-gain-LF and BRS-gain-6}min are both computed
within approximately the same frequency band around
0.1 Hz (see Figure 1, centre panels). However, BRS-gain-
6}min results in a significantly higher BRS value: 8.5
compared with 6.2 ms[mmHg−" (Table 2). There are two
effects that probably explain this difference. First, a
significantly lower coherence value was found for BRS-
gain-LF (c#fl 0.52) compared with BRS-gain-6}min (c#
fl 0.73) (Table 3, final column). This inherently results in
a lower BRS value, as will be discussed in the section
below. Secondly, the difference in origin between breath-
ing modulations and the spontaneous existing so-called
Mayer blood pressure waves (10 s waves ; 0.1 Hz)
[11,12,15] could also cause an overestimation of BRS.
Breathing causes, besides baroreflex-mediated respirat-
ory sinus arrhythmia, also non-baroreflex (though
breathing-coherent) variations in heart rate, originating
directly from the brain stem or evoked by lung stretch
receptors. These non-baroreflex-mediated variations in
heart rate will lead to an overestimation of BRS.
The two effects, i.e. the frequency dependency
(resulting in lower values) and the overestimation due to
respiration (resulting in higher values) may have a
counteracting effect on BRS-HF compared with BRS-
LF. The difference therefore may become small, but we
found that BRS-gain-HF is still higher than BRS-gain-LF
(7.5 and 6.2 ms[mmHg−" respectively ; P ! 0.05), and the
same holds for BRS-a-HF compared with BRS-a-LF (8.6
and 6.6 ms[mmHg−" respectively ; P ! 0.05). In an earlier
study of the effects of physical training on BRS, no
significant differences were found between HF and LF a
coefficients [10], while in a more recent study in
conscious cats our results were indeed confirmed [34].
Coherence
Irrespective of the method of assessing BRS, be it the
phenylephrine method [9], the sequence method [14], the
spectral a method [10] or the cross-spectral transfer
method [13], all rely on the assumption that observed
modulations in RR intervals are driven essentially by the
baroreflex in response to independent changes in systolic
blood pressure. To increase the specificity of the BRS
estimate, commonly a threshold is imposed on either the
correlation (time-domain methods) or the coherence
(frequency-domain methods). In general, a coherence
threshold that is too high will be too selective and bias for
instance reference values, in particular in an ill or elderly
population in whom heart rate variability is already low.
The coherence criterium of 0.7 in our study led to the
exclusion of approx. 15% of the studied population, a
group which appeared to be significantly older than those
that were included, but nonetheless clearly healthy.
A second effect, which has been recognized previously
[35,36], is the direct relationship between the height of
the coherence (c#) and the transfer function gain (BRS)
itself, in contrast with the a coefficient (Appendix 1).
BRS estimated by cross-spectral analysis is equal to the
square root of the power ratios (by definition the a
coefficient) [14], scaled by the coherence. The latter
factor compensates for non-coherent RR-interval varia-
bility, and will in practice always lead to lower BRS
estimates compared with the straightforward power ratio
(fla coefficient). Thus the coherence acts as a kind of
weighing function for the transfer gain, while for the a
coefficient it is only involved in selecting the RR intervals
and values of systolic blood pressure on which the
computation will be based. Our observations that the
absolute values of the a coefficient were consistently
higher than the transfer function gain parameters were in
line with this. Furthermore, as a consequence, for the
transfer gain it holds that the higher the imposed
coherence threshold, the higher the BRS outcome, which
is essentially shown in the present study.
Thirdly, as would be expected, metronome breathing
significantly increased coherence between blood pressure
and interval fluctuations. While the coherence threshold
of 0.5 was not met for all spontaneous LF and HF BRS
estimates, a coherence of 0.7 and higher was common for
all metronome breathing segments. In conclusion, a
squared coherence criterium of 0.5 seems appropriate for
spontaneous breathing tests, whereas for metronomic
breathing tests a higher squared coherence criteria of 0.7
can be applied.
Recording period
The minimal period of recording of blood pressure and
heart rate data sets required to obtain reliable spectral
estimates of BRS is in general an important matter of
concern. First, a clear distinction has to be made between
spontaneous breathing and metronome breathing data
sets. Robbe et al. [13] used, and the ESC Task Force [31]
recommended, 5 min of recording; however, this referred
to data obtained during spontaneous breathing. In the
case of metronome breathing at a particular frequency,
the power of heart rate and blood pressure variability is
importantly increased and concentrated in a relatively
small frequency band in which the BRS was computed.
The time series are also likely to become more stationary
(spectral parameters vary less over time) compared with
recordings during spontaneous breathing. Thus, in the
# 2000 The Biochemical Society and the Medical Research Society
379Baroreflex sensitivity in the elderly
case of metronome breathing and of applying the
respiration-evoked modulations in blood pressure and
heart rate, much shorter recording periods will be
sufficient to compute BRS. This seems to be confirmed
by our data, since coherence values were significantly
greater for the metronome breathing data (6}min) com-
pared with the spontaneous breathing data (LF band).
Secondly, the metronome breathing recordings should be
kept as short as possible (in particular the slow deep
breathing), in order to prevent hyperventilation, which
will alter central modulations of heart rate and blood
pressure control. A period of 1 min seems to be a
reasonable compromise.
Reproducibility study
In general, reproducibility was rather poor. For example,
for BRS-gain-LF and BRS-a-LF, the most applied non-
invasive BRS values, the RC and CV were 48% and 43%
for the transfer gain, and 50% and 39% for the a
coefficient. The rather high CV values indicate that a
single measurement is insufficient to characterize sub-
jects. This poor reproducibility may be partly attributable
to the advanced age of the subjects, leading to low BRS
values, which directly results in higher CVs (CV fl
S.D.
within
}mean
bothmeasurements
[100%). Reproducibility
may be improved by standardizing the conditions during
measurement, e.g. longer resting periods and carrying out
the duplicate measurements at the same time of the day.
However, the results presented here are more indicative
of daily practice, and in that sense more valuable.
However, clearly, a larger study confirming our findings
on reproducibility will be necessary. In this context, the
study by Herpin and Ragot [37] is worth mentioning,
since they report, for BRS [cross-spectral analysis ; mid-
frequency band (0.066–0.127 Hz)], 1-week and 1-year
reproducibility in 14 healthy subjects aged 23–51 years ;
RCs of 0.85 and 0.54 respectively were found.
Conclusions
From the present study, based on a carefully selected
healthy sample of a general population, we conclude that
non-invasively assessed BRS is still dependent on age
even in the elderly, but is also, importantly, dependent on
methodological choices. Of particular importance are :
(1) the choice to apply either the a coefficient or the
transfer-gain method; (2) the choice whether to use
respiration-induced or spontaneous existing LF varia-
bility for the spectral analysis ; (3) the choice of a band of
certain frequency; and (4) the choice of coherence
threshold. These conclusions emphasize the need for
standardization before a further spread in clinical practice
can be recommended. Since no international consensus
has yet been reached, we have presented several age-
specific reference values for several spectral methods,
breathing modes and frequency bands.
One cannot expect clear recommendations from the
current type of study alone as to which particular non-
invasive method of BRS analysis should be used. Also,
larger studies on reproducibility, determinants of auto-
nomic function test outcomes [32] and predictive power
are needed in order to reach a consensus for clinical use.
Nevertheless, we may draw some useful guidelines from
the data in the present study. The transfer-function
method to compute BRS is on theoretical grounds
preferable, since it truly is an estimate of reflex ‘transfer ’,
partly correcting for non-correlating noise sources, and
additionally providing the phase relationship between
changes in blood pressure and heart rate (results not
shown). The a coefficient has the advantage of being
conceptually simple, but always overestimates true trans-
fer gain, although it comes close to BRS gain when
coherence is high. Metronome breathing increases and
concentrates blood pressure and heart rate power within
a certain frequency band, therefore substantially in-
creasing coherence, and hence allowing shorter recording
periods. However, the trade-off will be a biased (over-
estimated) BRS due to respiration-induced, but non-
baroreflex-mediated, variations in heart rate. Although it
is a less specific baroreflex heart rate parameter, it still
will be an autonomic nervous function parameter. BRS
values depend on frequency. The advantages of assessing
BRS from fluctuations during slow breathing (6}min) are
the larger BRS values obtained at this frequency, the
larger coherence and the low CV. This particularly
becomes relevant in older and sicker patients. An
additional practical advantage may be that a BRS as-
sessment can be made from the same manoeuvre as the
classical expiration–inspiration difference in RR intervals
(Ewing). Consensus about what coherence criterion to
apply seems crucial for both the transfer-gain and a-
coefficient methods. It becomes less important, though,
when metronome (slow) breathing is applied, since
coherence is then sufficiently high.
In conclusion, age, breathing mode and breathing
frequency all affect the observed BRS value. Therefore
specific reference values for age, breathing mode and
breathing frequency should be used.
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APPENDIX 1
Transfer gain, a coefficient, squared
coherence and their relationship
In the relationships below, the baroreceptor heart rate
reflex is considered as a simple linear single-input}single-
output system, where s denotes the input signal (systolic
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blood pressure ; SBP) and i denotes the output signal (RR
interval ; RRI), S
ss
fl power-spectrum SBP, S
ii
fl power-
spectrum RRI, S
si
fl cross-spectrum SBP and RRI, and c
fl coherence. The gain of the transfer function between
SBP and RRI (BRS-gain) and the squared coherence are
computed directly from the cross-spectrum and respect-
ive input}output spectrum [21] according to the fol-
lowing two equations :
BRS-gain fl rS
si
r}S
ss
(A1.1)
c#fl rS
si
r#}S
ss
[S
ii
(A1.2)
Eqn (A1.2) can be rewritten as :
rS
si
r#fl c#[S
ss
[S
ii
(A1.3)
Fill eqn (A1.3) into eqn (A1.1) :
BRS-gain floc#[oS
ii
}S
ss
(A1.4)
By definition, the a coefficient is the square root of the
ratio of output and input spectrum [10] :
BRS-afloS
ii
}S
ss
(A1.5)
From eqns (A1.4) and (A1.5), the direct relationship
between the transfer function gain and the a coefficient
follows:
BRS-gain floc#[BRS-a (A1.6)
APPENDIX 2
Reference values obtained from linear
regression
The reference values were computed as the 90% pre-
diction intervals [24]. These intervals are computed by
means of linear regression, as follows. The general
formula is :
90% interval fl fitted value‡(t-value)[S.D.
fl yW ‡ts(yW )
with fitted value :
yW fl a›bx fl ya›b(xfixa ) (A2.2)
and the standard error :
s(yW ) fl S
yxA1› 1N›
(xfixa )#
R(x
i
fixa )#
(A2.3)
Given the standard error of the slope of the regression
line, i.e. :
S.E.(b) fl
S
yx
oR(x
i
fixa )#
(A2.4)
eqn (A2.3) can be rewritten as :
s#(yW ) fl s
yx
#01› 1N1›(xfixa )# S.E.#(b) (A2.5)
and thus the standard error can be computed as :
s(yW ) flAsyx#01› 1N1›(xfixa )# S.E.#(b) (A2.6)
the components of which are all readily available from
the output of a statistical software package.
Example
The 5% and 95% limits of BRS from the slow metro-
nome breathing test in the supine position for a 60-year-
old person were computed using eqns (A2.2), (A2.6) and
(A2.1). The intercept (a) fl 3.294, the regression
coefficient (b) flfi0.185, the mean age (x) fl 6.2378
decades, and the mean ln(BRS) (y) fl 2.1419 are sub-
stituted into eqn (A2.2) :
yW fl 2.1419›(fi0.185)(6.0fi6.2378) fl 2.1859
Accordingly, the variance of the residuals (s#
xy
) fl 0.239,
the standard error of the regression coefficient S.E.
(b) fl 0.053 and N fl 167 are substituted into eqn (A2.6) :
s(yW ) flo(0.239)(1›1}167)›(6.0fi6.2378)#(0.053)#fl
o0.2406 fl 0.4904
With a t-value fl 1.645 and the above estimated values
substituted into eqn (A2.1), the 90% prediction interval
becomes (in logarithmic values) :
2.1859‡(1.645)(0.4904) fl [1.375; 2.997]
Thus the 90% prediction interval is : e".$(&fl 4.0 to
e#.**(fl 20.0 ms[mmHg−"
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